These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 6575210

  • 1. Antiestrogenic action of 3-hydroxytamoxifen in the human breast cancer cell line MCF-7.
    Roos W, Oeze L, Löser R, Eppenberger U.
    J Natl Cancer Inst; 1983 Jul; 71(1):55-9. PubMed ID: 6575210
    [Abstract] [Full Text] [Related]

  • 2. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
    Katzenellenbogen BS, Norman MJ, Eckert RL, Peltz SW, Mangel WF.
    Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
    [Abstract] [Full Text] [Related]

  • 3. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY, Ruh TS, Mangel WF, Katzenellenbogen BS.
    Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
    [Abstract] [Full Text] [Related]

  • 4. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA, Lippman ME, Katzenellenbogen BS.
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [Abstract] [Full Text] [Related]

  • 5. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
    Murphy CS, Parker CJ, McCague R, Jordan VC.
    Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
    [Abstract] [Full Text] [Related]

  • 6. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
    Reiner GC, Katzenellenbogen BS.
    Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
    [Abstract] [Full Text] [Related]

  • 7. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
    Dix CJ, Jordan VC.
    Endocrinology; 1980 Dec; 107(6):2011-20. PubMed ID: 7191796
    [Abstract] [Full Text] [Related]

  • 8. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC, Katzenellenbogen BS, Bindal RD, Katzenellenbogen JA.
    Cancer Res; 1984 Jun; 44(6):2302-8. PubMed ID: 6547074
    [Abstract] [Full Text] [Related]

  • 9. Interleukin 1 alpha blocks estradiol-stimulated growth and down-regulates the estrogen receptor in MCF-7 breast cancer cells in vitro.
    Danforth DN, Sgagias MK.
    Cancer Res; 1991 Mar 01; 51(5):1488-93. PubMed ID: 1997187
    [Abstract] [Full Text] [Related]

  • 10. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.
    Vignon F, Lippman ME, Nawata H, Derocq D, Rochefort H.
    Cancer Res; 1984 May 01; 44(5):2084-8. PubMed ID: 6713400
    [Abstract] [Full Text] [Related]

  • 11. Antiestrogenic activity of DP-TAT-59, an active metabolite of TAT-59 against human breast cancer.
    Toko T, Shibata J, Nukatsuka M, Yamada Y.
    Cancer Chemother Pharmacol; 1997 May 01; 39(5):390-8. PubMed ID: 9054952
    [Abstract] [Full Text] [Related]

  • 12. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture.
    Jain PT, Pento JT, Magarian RA.
    Anticancer Res; 1992 May 01; 12(3):585-90. PubMed ID: 1622114
    [Abstract] [Full Text] [Related]

  • 13. Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018.
    Bronzert DA, Greene GL, Lippman ME.
    Endocrinology; 1985 Oct 01; 117(4):1409-17. PubMed ID: 4029083
    [Abstract] [Full Text] [Related]

  • 14. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
    Gottardis MM, Robinson SP, Satyaswaroop PG, Jordan VC.
    Cancer Res; 1988 Feb 15; 48(4):812-5. PubMed ID: 3338079
    [Abstract] [Full Text] [Related]

  • 15. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL, Sugimoto Y, Liu S, Ye W, Wang LS, Huang YW, Lin YC.
    Anticancer Res; 2006 Feb 15; 26(3A):1773-84. PubMed ID: 16827106
    [Abstract] [Full Text] [Related]

  • 16. Estrogenic activity and metabolism of n-butyl benzyl phthalate in vitro: identification of the active molecule(s).
    Picard K, Lhuguenot JC, Lavier-Canivenc MC, Chagnon MC.
    Toxicol Appl Pharmacol; 2001 Apr 15; 172(2):108-18. PubMed ID: 11298497
    [Abstract] [Full Text] [Related]

  • 17. Estrogenic activity of naturally occurring anthocyanidins.
    Schmitt E, Stopper H.
    Nutr Cancer; 2001 Apr 15; 41(1-2):145-9. PubMed ID: 12094617
    [Abstract] [Full Text] [Related]

  • 18. Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines.
    Pihie AH, Stanslas J, Din LB.
    Anticancer Res; 1998 Apr 15; 18(3A):1739-43. PubMed ID: 9673398
    [Abstract] [Full Text] [Related]

  • 19. [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].
    Bachmann-Moisson N, Barberi-Heyob M, Merlin JL, Ledrich ML, Batt AM, Guillemin F.
    Bull Cancer; 1996 Oct 15; 83(10):808-15. PubMed ID: 8952630
    [Abstract] [Full Text] [Related]

  • 20. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
    Lobaccaro C, Pons JF, Duchesne MJ, Auzou G, Pons M, Nique F, Teutsch G, Borgna JL.
    J Med Chem; 1997 Jul 04; 40(14):2217-27. PubMed ID: 9216841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.